0001354488-16-005954.txt : 20160121
0001354488-16-005954.hdr.sgml : 20160121
20160121211027
ACCESSION NUMBER: 0001354488-16-005954
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160119
FILED AS OF DATE: 20160121
DATE AS OF CHANGE: 20160121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cellular Biomedicine Group, Inc.
CENTRAL INDEX KEY: 0001378624
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 861032927
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100
CITY: CUPERTINO
STATE: CA
ZIP: 95014
BUSINESS PHONE: (408) 973-7884
MAIL ADDRESS:
STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100
CITY: CUPERTINO
STATE: CA
ZIP: 95014
FORMER COMPANY:
FORMER CONFORMED NAME: EastBridge Investment Group Corp
DATE OF NAME CHANGE: 20061019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chan Andrew K
CENTRAL INDEX KEY: 0001569877
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36498
FILM NUMBER: 161354601
MAIL ADDRESS:
STREET 1: 530 UNIVERSITY AVENUE, #17
CITY: PALO ALTO
STATE: CA
ZIP: 94301
4
1
issuerdirect_section16.xml
PRIMARY DOCUMENT
X0306
4
2016-01-19
0
0001378624
Cellular Biomedicine Group, Inc.
CBMG
0001569877
Chan Andrew K
19925 STEVENS CREEK BLVD., SUITE 100
CUPERTINO
CA
95014
1
SVP Corp Bus Dev
Common Stock
2016-01-19
4
M
0
1516
5.61
A
147273
D
Common Stock
2016-01-19
4
S
0
1516
12.07
D
145757
D
Common Stock
2016-01-21
4
M
0
1296
3.00
A
147053
D
Common Stock
2016-01-21
4
S
0
1296
13.87
D
145747
D
Non- Qualified Stock Option (right to buy) (2013 Plan)
5.61
2016-01-19
4
M
0
1516
0
D
2023-05-16
Common Stock
1516
39420
D
Non- Qualified Stock Option (right to buy) (2011 Plan)
3.00
2016-01-21
4
M
0
1296
0
D
2023-02-20
Common Stock
1296
40187
D
The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
On December 22, 2015, due to miscommunications with regard to the nature of transactions undertaken by the reporting person in September 2015, the reporting person mistakenly reported the number of shares of common stock and derivative securities of the issuer owned by him after certain transactions undertaken in December 2015. As a result, the number of outstanding securities owned by the reporting person after each transaction as reported on this form reflects corrections of the reporting errors made in December 2015.
The option vested according to the following schedule: 1/31st per month following the vesting commencement date of May 16, 2014.
The option vested according to the following schedule: 1/36th per month following the vesting commencement date of February 20, 2013.
/s/ Andrew Chan
2016-01-21